Vistagen Therapeutics (VTGN) Return on Capital Employed Growth (1y) (2018 - 2026)
Vistagen Therapeutics (VTGN) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | -13,393.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,992.00 |
| Dec 31, 2025 | -5,736.00 |
| Sep 30, 2025 | -6,146.00 |
| Jun 30, 2025 | -5,714.00 |
| Mar 31, 2025 | -4,692.00 |
| Dec 31, 2024 | -1,908.00 |
| Sep 30, 2024 | 9,384.00 |
| Jun 30, 2024 | 29,786.00 |
| Mar 31, 2024 | 25,759.00 |
| Dec 31, 2023 | 16,499.00 |
| Sep 30, 2023 | 848.00 |
| Jun 30, 2023 | -22,828.00 |
| Mar 31, 2023 | -22,241.00 |
| Dec 31, 2022 | -16,423.00 |
| Sep 30, 2022 | -11,369.00 |
| Jun 30, 2022 | -8,095.00 |
| Mar 31, 2022 | -4,505.00 |
| Dec 31, 2021 | -1,763.00 |
| Sep 30, 2021 | 12,372.00 |
| Jun 30, 2021 | 51,430.00 |